Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The cosmetic industry should adapt to the varied beauty standards of ethnic groups and offer specialized treatments.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Low-level laser therapy may improve hair regrowth and thickness for androgenetic alopecia, but more research is needed.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

A systematic approach is crucial for managing hair loss in women.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Some plants used in traditional medicine may help treat cancer because they contain proteins that can inactivate ribosomes.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.